GRIFOLS | GRF - Selling And Administration Expenses

Stock Price
8.95
Daily Change
0 0%
Monthly
-0.11%
Yearly
5.12%
Q2 Forecast
9.40

GRIFOLS reported EUR275.3M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alcon AG USD 901M 36M Dec/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 18.97M 1.03M Dec/2025
argenx SE USD 429.62M 93.32M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Cie Automotive EUR 315.66M 28.06M Dec/2024
Demant DKK 6.09B 135M Dec/2025
Ence Energia y Celulosa EUR 29.1M 2M Sep/2024
Essilor EUR 5.62B 4.53B Dec/2025
Ferrovial EUR 906M 52M Dec/2024
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 208M 60M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Inditex EUR 2.51B 7.98B Jan/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Smith & Nephew USD 1.42B 65M Dec/2025
UCB EUR 1.47B 193M Dec/2025
Viscofan EUR 72.59M 4.52M Mar/2025